(Q34994259)

English

Changes in prescribed drug doses after market introduction

scientific article

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Changes in prescribed drug doses after market introduction (English)

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

author name string

Eibert R Heerdink

1

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

John Urquhart

2

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Hubert G Leufkens

3

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

publication date

1 September 2002

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Pharmacoepidemiology and Drug Safety

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

447-453

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Study designs for dose-ranging

1 reference

https://api.crossref.org/works/10.1002%2FPDS.745

21 January 2018

Opportunities for integration of pharmacokinetics, pharmacodynamics, and toxicokinetics in rational drug development

1 reference

https://api.crossref.org/works/10.1002%2FPDS.745

21 January 2018

The interface between pharmacoepidemiology and pharmacogenetics

1 reference

https://api.crossref.org/works/10.1002%2FPDS.745

21 January 2018

Proof of efficacy trials: choosing the dose

1 reference

https://api.crossref.org/works/10.1002%2FPDS.745

21 January 2018

What have we learned from pharmacokinetic and pharmacodynamic theories?

1 reference

https://api.crossref.org/works/10.1002%2FPDS.745

21 January 2018

Variation in antibiotic use in the European Union

1 reference

https://api.crossref.org/works/10.1002%2FPDS.745

21 January 2018

Lessons from international experience in controlling pharmaceutical expenditure. II: Influencing doctors.

1 reference

https://api.crossref.org/works/10.1002%2FPDS.745

21 January 2018

Learning versus confirming in clinical drug development

1 reference

https://api.crossref.org/works/10.1002%2FPDS.745

21 January 2018

Thymus volume correlates with the progression of vertical HIV infection

1 reference

https://api.crossref.org/works/10.1002%2FPDS.745

21 January 2018

Efficacy of low-density-lipoprotein lowering with statins

1 reference

https://api.crossref.org/works/10.1002%2FPDS.745

21 January 2018

Identifiers

10.1002/PDS.745

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34994259&oldid=1593243775"